For example, recent data demonstrated that TH-302 (evofosfamide), a hypoxia-activated prodrug, exerts strong anticancer activity in Ewing sarcoma cells under low-oxygen conditions by inducing DNA damage, mitochondrial dysfunction, and apoptosis, independent of p53 status [44]. This evidence concerns the gene TP53 and Ewing sarcoma.